pirfenidonenintedanibmycophenolate mofetiltreprostiniltocilizumab
…ow (see section on Current treatments). The antifibrotic drugs, pirfenidone and nintedanib, are established treatments for idiopathic pulmo…
53articles mentioning drugs
88drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Tocilizumab ×
Tocilizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Tocilizumab
53 articles · page 1 of 5rituximabtocilizumabprednisoneMemorial Sloan Kettering Cancer Center Institutional Review Boardbullous pemphigoidColumbia University Institutional Review Boardarthritisosteoporosis
…atients were enrolled based on published data supporting use of rituximab or tocilizumab. Each arm aimed to enroll 15 patients. Primary e…
mycophenolate mofetiltocilizumabrituximabmethotrexateTCZ
…for systemic sclerosis (SSc) treatment, which newly recommended mycophenolate mofetil (MMF), rituximab (RTX), and tocilizumab (TCZ) as options for sk…
tocilizumabreperfusion therapyacute ischaemic stroke (AIS)acute anterior circulation large vessel occlusion (LVO)ischaemia-reperfusion damage
…ute ischaemic stroke (AIS). Preclinical research indicates that tocilizumab, an interleukin-6 receptor antagonist, can attenuate ischaemia-…
Tocilizumabrheumatoid arthritisHospital de Clínicas de Porto AlegreTRDNCT07052058major depressive disorder
…tional studies targeting IL-6 in this population remain scarce. Tocilizumab is a humanised monoclonal antibody that inhibits IL-6 signallin…
Tocilizumabcorticosteroidshaematologic malignanciesuniversity hospitalCRSCAR-T cell therapycytokine release syndromemultiorgan failure
…was uncommon in both groups (10% in trials vs 1% in real life). Tocilizumab was administered in all trial cases (20/20) versus 66% (200/303…
tocilizumabadalimumabrheumatoid arthritisadult-onset Still’s disease (AOSD)AOSDPotassium replacement
…mmol/L) and acute flaccid paralysis after his third intravenous tocilizumab infusion. He had no prior neurological or electrolyte disturban…
tocilizumababataceptrituximabTNFirheumatoid arthritisRADANBIO
…1.38), TNFi 1.01 (0.66 to 1.54), rituximab 1.14 (0.71 to 1.84), tocilizumab 1.48 (0.92 to 2.40). LDA and remission rates were unaffected by…
tocilizumabMethotrexateglucocorticoidgiant cell arteritisneurodegenerative diseasesosteoporotic fractureshypertensionGCASystème National des Données de Santé
…trexate use increased until 2020 and plateaued thereafter while tocilizumab prescriptions rose, reaching over 25% in 2022. Male sex and bas…
tocilizumabprednisoneTNF-iSarcopeniarheumatoid arthritisRA
…or inhibitors (TNF-i) use (OR 0.502, 95% CI 0.312 to 0.808) and tocilizumab use (OR 0.493, 95% CI 0.304 to 0.799) were associated with sarc…
mycophenolate mofetiltofacitinibtocilizumabrituximabmethotrexateupadacitinibMTXprednisoneMMFJanus kinase inhibitors+1 more
…citinib or upadacitinib), rituximab, tocilizumab, methotrexate, mycophenolate mofetil, or glucocorticoids (>=10 mg prednisone equivalent daily) for m…
methotrexatetocilizumabTCZsystemic sclerosis (SSc)interstitial lung disease (ILD)arthritisSScPAHDisease Activity Score 28SSc-ILD
…n TCZ monotherapy, the most common combination therapy was with methotrexate(35%). In SSc-ILD patients, a significant decline of %pFVC from …